Lorazepam
Lorazepam is a benzodiazepine (a calming, sedating medicine) used for anxiety disorders as a tablet or oral liquid, and as an injection for status epilepticus (a prolonged, dangerous seizure) and for sedation before surgery.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 105 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Lorazepam (Ativan) is a familiar benzodiazepine, on the market since about 1980 and available generically, that boosts GABA, the brain's natural calming chemical, to treat anxiety disorders, usually for short stretches, and, as an injection, status epilepticus (a prolonged, dangerous seizure) and sedation before surgery. Short-term use is usually well tolerated, and drowsiness and unsteadiness are what people notice most, more so in older adults. Its boxed warning covers dangerously slowed breathing when combined with opioids, plus misuse, addiction and physical dependence, and alcohol adds to the same breathing risk. After regular use, never stop suddenly, because withdrawal can be life-threatening, so plan any taper with your prescriber.
Clinical pearls
- Mix the oral concentrate with water, juice, applesauce or pudding using the supplied dropper, and finish it right away.
- Loreev XR is taken once each morning, swallowed whole or sprinkled on applesauce, and never crushed or chewed.
- Valproate (a seizure and mood medicine) and probenecid (a gout medicine) raise lorazepam levels, so dose reductions may be needed.
- If you take it long term, expect periodic blood counts and liver tests, which the label advises.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Taking lorazepam with opioids can cause extreme sleepiness, slowed breathing, coma and death. Doctors should reserve this combination for when no other options work, using the lowest dose and shortest time.
Benzodiazepines also carry a risk of abuse, misuse and addiction, which can lead to overdose or death. Risk is higher when mixed with other medicines, alcohol or illicit drugs.
Continued use can cause physical dependence. Stopping suddenly or cutting the dose too fast can cause withdrawal reactions that may be life-threatening. Your doctor should lower the dose gradually. This boxed warning is shown for Loreev XR.
Patient information guide A plain-language walkthrough of Lorazepam, written from its FDA label.
What Lorazepam is used for
▾
Lorazepam is used for different conditions depending on the product:
- Lorazepam and Ativan tablets, and lorazepam oral solution (concentrate): anxiety disorders, or short-term relief of anxiety symptoms, including anxiety with depressive symptoms.
- Ativan and Lorazepam injection: status epilepticus.
- Ativan and Lorazepam injection: in adults, sedation, anxiety relief and reduced memory of surgery day before an operation.
- Loreev XR extended-release capsules: anxiety disorders in adults stable on lorazepam tablets three times daily.
How Lorazepam works
▾
Lorazepam binds to the benzodiazepine site on GABA-A receptors in the brain. This strengthens GABA, a chemical that calms nerve signaling. That calming effect eases anxiety, causes sedation and reduces seizure activity.
Lorazepam dosage
▾
Lorazepam tablets and oral concentrate are taken by mouth, with dose and duration tailored to you. Mix the concentrate into liquid or soft food and use it all right away.
- Loreev XR: once daily in the morning, swallowed whole or sprinkled on applesauce. Do not crush or chew.
- Injection: given by a healthcare professional into a muscle or vein.
Follow your prescriber and the label, and ask your pharmacist about missed doses.
Dosing details from the FDA-approved label
From the Lorazepam prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Status epilepticus (intravenous injection, patients 18 years and older)
- 4 mg given slowly (2 mg/min)
- If seizures continue or recur after a 10- to 15-minute observation period, an additional 4 mg intravenous dose may be slowly administered
- If seizures cease, no additional dose is required; experience with further doses is very limited
- Status epilepticus (intramuscular injection)
- IM ATIVAN is not preferred because therapeutic lorazepam levels may not be reached as quickly as with IV administration
- May prove useful when an intravenous port is not available
- The label gives no specific IM dose for status epilepticus
- Preanesthetic (intramuscular injection)
- 0.05 mg/kg, administered at least 2 hours before the anticipated operative procedure
- Maximum: 4 mg
- Individualize the dose; not recommended in patients less than 18 years of age
- Preanesthetic, sedation and relief of anxiety (intravenous injection)
- Initial dose 2 mg total, or 0.02 mg/lb (0.044 mg/kg), whichever is smaller, given 15 to 20 minutes before the procedure
- For greater lack of recall, doses as high as 0.05 mg/kg may be given
- Maximum: 4 mg total
- Ordinarily should not exceed the initial dose in patients over 50 years of age; not recommended under 18 years
- Loreev XR (extended-release capsule), patients switched from lorazepam tablets three times daily
- Once daily in the morning, equal to the total daily dose of lorazepam tablets (e.g., 1 mg three times daily = LOREEV XR 3 mg once daily)
- For dosage increase, discontinue LOREEV XR and switch to lorazepam tablets; capsules may be swallowed whole or sprinkled on applesauce, do not crush or chew
- Elderly patients and patients with hepatic disease
- No dosage adjustments are needed
- Patients with renal disease
- For acute dose administration, adjustment is not needed
- Caution if frequent doses are given over relatively short periods of time
- Patients taking probenecid or valproate
- Reduce the dose of ATIVAN by 50%
- Female patients taking oral contraceptives
- It may be necessary to increase the dose of ATIVAN
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Recommended dosage of LOREEV XR is equal to the total daily dose of lorazepam tablets (at the previous three times daily dosage) ( 2.1 ) Administer LOREEV XR orally once daily in the morning ( 2.2 ) Capsules may be swallowed whole or opened and the entire contents sprinkled onto applesauce. Do not crush or chew ( 2.2 ) For dosage adjustments, discontinue LOREEV XR and switch to lorazepam tablets to adjust dosage ( 2.3 ) 2.1 Recommended Dosage Initiate LOREEV XR in patients who are being treated with lorazepam tablets, administered three times daily in evenly divided doses (refer to the Prescribing Information of lorazepam tablets for the recommended dosage of lorazepam tablets). Discontinue lorazepam tablets and administer the first dose of LOREEV XR in the morning the day after the final dose of lorazepam tablets. The recommended once daily dosage of LOREEV XR is equal to the total daily dose of lorazepam tablets. For example, the recommended dosage for patients who have been receiving lorazepam tablets at a dosage of 1 mg three times daily is LOREEV XR 3 mg once daily in the morning. The effectiveness of LOREEV XR use for more than 4 months has not been assessed in clinical studies. Healthcare providers should periodically re-evaluate longer term use of LOREEV XR. 2.2 Administration Information Administer LOREEV XR orally once daily, in the morning, with or without food. Do not crush or chew LOREEV XR. Swallow LOREEV XR capsules whole or open the capsule and sprinkle the entire contents over a tablespoon of applesauce, followed by drinking water. Consume all the sprinkled LOREEV XR in its entirety, (without chewing) within 2 hours; do not store for future use. 2.3 Dosage Increase for Inadequate Clinical Response If the clinical response to LOREEV XR is inadequate and a dosage increase in needed, discontinue LOREEV XR and switch to lorazepam tablets to increase the dosage. If an adequate clinical response is achieved with a stable, evenly divided three times daily dosage of lorazepam tablets, resume LOREEV XR once daily dosing with the total daily dose of lorazepam tablets [see Dosage and Administration ( 2.1 )] . 2.4 Discontinuation or Dosage Reduction of LOREEV XR To reduce the risk of withdrawal reactions, use a gradual taper to discontinue LOREEV XR or reduce the dosage.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Lorazepam side effects
▾
Common effects are sedating and affect balance.
Common side effects
- Drowsiness or sleepiness
- Low blood pressure (with the injection for status epilepticus)
- Unsteadiness
- Sedation, which tends to increase with age
- More sedation in older adults
When to get medical help
- Slowed or shallow breathing, extreme sleepiness or being hard to wake (especially with opioids or alcohol)
- Seizures or other withdrawal symptoms after stopping suddenly or cutting the dose too fast
- Worsening depression or thoughts of suicide
- Unusual agitation, irritability, aggression or confusion (paradoxical reactions)
- Signs of misuse or addiction, such as taking more than prescribed
- Allergic-type reactions, including asthma symptoms, with Loreev XR 1 mg capsules (contain tartrazine/FD&C Yellow No. 5)
- Pain during an injection into a vein (the injection should be stopped right away)
Lorazepam warnings and precautions
▾
- Opioids: combined use can cause slowed breathing, coma and death.
- Abuse and addiction: risk of misuse, overdose and death.
- Dependence and withdrawal: stopping suddenly can cause life-threatening withdrawal, so a gradual taper is needed.
- Sedation: avoid driving and alcohol.
- Depression: it may emerge or worsen.
- Paradoxical reactions: agitation or aggression, possibly more likely in older adults.
Lorazepam interactions
▾
Lorazepam can add to the effects of other sedating drugs.
- Opioids: dangerous breathing suppression.
- Alcohol: more sedation, and it should be avoided.
- Other CNS depressants and antidepressants: additive sedation.
- Clozapine, loxapine, haloperidol: serious reactions reported.
- Scopolamine (with the injection): more sedation and hallucinations.
- Valproate and probenecid: raise lorazepam levels.
- Oral contraceptives: may lower lorazepam levels.
Interactions listed in the FDA-approved label
From the Lorazepam prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Opioids: Concomitant use increases the risk of respiratory depression, and benzodiazepines can significantly worsen opioid-related respiratory depression. Monitor patients closely for respiratory depression and sedation.
- Other CNS depressants (ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, other antidepressants): Injectable lorazepam produces additive depression of the central nervous system. Caution is advised if concomitant administration is required.
- Scopolamine: An increased incidence of sedation, hallucinations and irrational behavior has been observed with injectable lorazepam. Caution is advised if concomitant administration is required.
- Loxapine: Rare reports of significant respiratory depression, stupor and/or hypotension. Caution is advised if concomitant administration is required.
- Clozapine: Marked sedation, excessive salivation, ataxia, and, rarely, death have been reported. Caution is advised if concomitant administration is required.
- Haloperidol: Apnea, coma, bradycardia, arrhythmia, heart arrest, and death have been reported. Caution is advised if concomitant administration is required.
- Metoprolol, cimetidine, ranitidine, disulfiram, propranolol, metronidazole, propoxyphene: No effect on the pharmacokinetics of lorazepam. No change in Lorazepam Injection dosage is necessary.
- Valproate: Decreased total clearance of lorazepam by 40% and decreased formation rate of lorazepam glucuronide by 55%; lorazepam plasma concentrations were about two-fold higher for at least 12 hours post-dose. Reduce lorazepam dosage to 50% of the normal adult dose.
- Oral contraceptive steroids: 55% decrease in half-life, 50% increase in volume of distribution, and an almost 3.7-fold increase in total clearance of lorazepam. It may be necessary to increase the dose of Lorazepam Injection in female patients taking oral contraceptives.
- Probenecid: Prolonged lorazepam half-life by 130% and decreased its total clearance by 45%. Reduce Lorazepam Injection dosage by 50% when coadministered with probenecid.
Read the label’s full interactions text
7 DRUG INTERACTIONS Table 1 presents clinically significant interactions with LOREEV XR. Use with Opioids: Increase the risk of respiratory depression ( 7 ) CNS depressants: Additive CNS depressant effects (7) Alcohol: Avoid use. Increases the release rate of LOREEV XR (7) UGT Inhibitors: Avoid initiation of UGT inhibitors. Dose reduction requires switching to lorazepam tablets for dose adjustment (7) Table 1: Clinically Significant Drug Interactions with LOREEV XR. Opioids Clinical Impact The concomitant use of benzodiazepines and opioids increases the risk of respiratory depression because of actions at different receptor sites in the CNS that control respiration. Benzodiazepines interact at gamma-aminobutyric acid (GABA A ) sites and opioids interact primarily at mu receptors. When benzodiazepines and opioids are combined, the potential for benzodiazepines to significantly worsen opioid-related respiratory depression exists [see Warnings and Precautions ( 5.1 )] . Intervention Limit dosage and duration of concomitant use of LOREEV XR and opioids, and monitor patients closely for respiratory depression and sedation. Alcohol Clinical Impact Based on an in vitro study, alcohol increases the release rate of LOREEV XR [see Clinical Pharmacology ( 12.3 )] . Intervention Avoid concomitant use of alcohol during treatment with LOREEV XR [see Warnings and Precautions ( 5.4 )] . CNS-Depressants Clinical Impact Benzodiazepines, including LOREEV XR, increase CNS-depressant effects when administered with other CNS depressants. Concomitant use of clozapine and LOREEV XR may produce marked sedation, excessive salivation, hypotension, ataxia, delirium, and respiratory arrest. Intervention Avoid co-administration of alcohol with LOREEV XR. Use caution if LOREEV XR is co-administered with other CNS-depressants [see Warnings and Precautions (5.4)] .
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Lorazepam
▾
- Allergy to benzodiazepines or injection ingredients.
- Sleep apnea, severe breathing problems or narrow-angle glaucoma (injection).
- Depression, psychosis or substance misuse history.
- Liver or kidney disease.
- Pregnancy: possible fetal harm and newborn sedation or withdrawal.
- Breastfeeding is not recommended with Loreev XR.
- Older adults are more sensitive to sedation.
- Premature infants must not receive the injection (benzyl alcohol).
Lorazepam overdose
▾
Too much can cause drowsiness, confusion, poor coordination and weak muscle tone, and in severe cases slowed breathing and coma. Mixing with alcohol or opioids can be fatal. Treatment is supportive care, and you should call the Poison Help line at 1-800-222-1222.
What Lorazepam does in the body
▾
Lorazepam enhances GABA's action in the brain, producing antianxiety effects, sedation and reduced seizure activity. Before surgery, the injection causes drowsiness, less anxiety and reduced memory of the day. These effects usually last 6 to 8 hours, though coordination can be impaired longer.
How your body processes Lorazepam
▾
Injected lorazepam is absorbed rapidly into the blood, peaking within about 3 hours after a muscle injection. It is broken down in the liver into an inactive form that the kidneys remove. Its half-life is about 14 hours after injection, and about 20 hours with Loreev XR, which peaks around 14 hours after dosing.
How to store Lorazepam
▾
Keep out of reach of children. Store at 20° - 25° C (68° - 77° F) . Dispense in a tight container.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Lorazepam
119 supplements and herbal products have documented interactions with Lorazepam in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 8
- Moderate · 94
- Minor · 17
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Lorazepam has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Lorazepam: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Lorazepam — the kind of thing our pharmacy team would talk through with you at the counter.
What is lorazepam for?
▾
How should I take it?
▾
Can I drink alcohol or take opioids with it?
▾
Can I stop it suddenly?
▾
What side effects should I expect?
▾
Is it safe in pregnancy or while breastfeeding?
▾
Is Lorazepam available over the counter?
▾
Is Lorazepam a controlled substance?
▾
When was Lorazepam first available?
▾
Who makes Lorazepam?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Lorazepam on HelloPharmacist
Lorazepam forms and strengths (how it comes)
Lorazepam is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Lorazepam inactive ingredients by manufacturer.
Tablet
How this form is used
- Ativan tablets and Lorazepam tablets are used for anxiety disorders or short-term relief of anxiety symptoms.
- Ativan tablets are taken by mouth, with dose, frequency and duration individualized to your response.
- Lorazepam tablets are taken by mouth, and your prescriber sets the schedule.
Injection
How this form is used
- Ativan Injection and Lorazepam Injection are used to treat status epilepticus.
- Ativan Injection and Lorazepam Injection are used in adults for sedation, anxiety relief and reduced memory of events before surgery.
- Ativan Injection and Lorazepam Injection are given by a healthcare professional, and airway equipment must be on hand before intravenous use.
- Ativan Injection and Lorazepam Injection contain benzyl alcohol.
Extended-release capsule
How this form is used
- Loreev XR is for anxiety disorders in adults already stable on lorazepam tablets taken three times daily.
- Loreev XR is taken by mouth once daily in the morning.
- Loreev XR capsules may be swallowed whole or opened and sprinkled on applesauce. Do not crush or chew.
- Loreev XR is not used to adjust the dose. The prescriber switches back to lorazepam tablets for adjustments.
Oral solution
How this form is used
- Lorazepam oral solution (concentrate) is used for anxiety disorders or short-term relief of anxiety symptoms.
- Lorazepam oral concentrate should be mixed with liquid or soft food such as water, juice, applesauce or pudding.
- Use only the supplied calibrated dropper or syringe.
- Consume the entire mixture right away and do not store it for later.
Lorazepam on the U.S. market: products, makers and brands
How Lorazepam appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
36 companies list 147 Lorazepam product records with the FDA, mostly as tablet, injection, extended-release capsule; the earliest marketing or approval year on record is 1977. Brand names on the directory include Ativan, Lorazepam Intensol, Loreev Xr and 1 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (15) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Lorazepam is used (Medicaid data)
A general measure of how commonly Lorazepam is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Lorazepam is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Lorazepam prescribed? Of the 1,601 medications we measure, Lorazepam ranks #108 by Medicaid prescriptions — more than 93% of them.
Utilization by Lorazepam product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
lorazepam 1 MG Oral Tablet Most dispensed
Summed across the 16 of 294 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197901
lorazepam 0.5 MG Oral Tablet
Summed across the 14 of 273 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197900
lorazepam 2 MG Oral Tablet
Summed across the 12 of 173 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197902
1 ML lorazepam 2 MG/ML Injection
Summed across the 5 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1665188
lorazepam 2 MG/ML Oral Solution
Summed across the 3 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311376
lorazepam 2 MG/ML Injectable Solution
Summed across the 5 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 238100
1 ML lorazepam 2 MG/ML Cartridge
Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 763028
24 HR lorazepam 3 MG Extended Release Oral Capsule
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2569577
24 HR lorazepam 2 MG Extended Release Oral Capsule
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2569573
24 HR lorazepam 1 MG Extended Release Oral Capsule
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2569564
1 ML lorazepam 4 MG/ML Injection
Summed across the 2 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1665326
24 HR lorazepam 1.5 MG Extended Release Oral Capsule
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2594600
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Lorazepam, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 62 of 786 listed Lorazepam NDCs with Medicaid activity.
Compare Lorazepam products
A representative set of FDA-listed product records for Lorazepam — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release capsule | ||||
| 1.5 mg | Oral | A-S Medication Solutions | NDA | View NDC → |
| 1 mg | Oral | Almatica Pharma LLC | NDA | View NDC → |
| 1.5 mg | Oral | Almatica Pharma LLC | NDA | View NDC → |
| 2 mg | Oral | Almatica Pharma LLC | NDA | View NDC → |
| 3 mg | Oral | Almatica Pharma LLC | NDA | View NDC → |
| 💊Injection | ||||
| 2 mg/mL | Intramuscular, Intravenous | Civica, Inc. | NDA | View NDC → |
| 2 mg/mL | Intramuscular, Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 2 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. × 7 listings | NDA | View NDC → |
| 4 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. × 6 listings | NDA | View NDC → |
| 2 mg/mL | Intramuscular, Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 2 mg/mL | Intramuscular, Intravenous | International Medication Systems, Limited | ANDA | View NDC → |
| 2 mg/mL | Intramuscular, Intravenous | Remedyrepack Inc. | ANDA | View NDC → |
| 💊Oral solution | ||||
| 2 mg/mL | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 2 mg/mL | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 2 mg/mL | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 2 mg/mL | Oral | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 2 mg/mL | Oral | Pharmaceutical Associates, Inc. | ANDA | View NDC → |
| 💊Tablet | ||||
| 1 mg | Oral | A-S Medication Solutions × 4 listings | ANDA | View NDC → |
| 1 mg | Oral | Advanced Rx of Tennessee, LLC | ANDA | View NDC → |
| 0.5 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 1 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 2 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 0.5 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 6 listings | ANDA | View NDC → |
| 1 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 5 listings | ANDA | View NDC → |
| 2 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 5 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Aurolife Pharma LLC | ANDA | View NDC → |
| 1 mg | Oral | Aurolife Pharma LLC | ANDA | View NDC → |
| 2 mg | Oral | Aurolife Pharma LLC | ANDA | View NDC → |
| 0.5 mg | Oral | Bausch Health US LLC | NDA | View NDC → |
| 1 mg | Oral | Bausch Health US LLC | NDA | View NDC → |
| 2 mg | Oral | Bausch Health US LLC | NDA | View NDC → |
| 0.5 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 1 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 2 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 0.5 mg | Oral | Clinical Solutions Wholesale, LLC | ANDA | View NDC → |
| 1 mg | Oral | Clinical Solutions Wholesale, LLC × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | Clinical Solutions Wholesale, LLC × 2 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 1 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 2 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 0.5 mg | Oral | Direct Rx | ANDA | View NDC → |
| 0.5 mg | Oral | DirectRx | ANDA | View NDC → |
| 0.5 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Leading Pharma, LLC | ANDA | View NDC → |
| 1 mg | Oral | Leading Pharma, LLC | ANDA | View NDC → |
| 2 mg | Oral | Leading Pharma, LLC | ANDA | View NDC → |
| 0.5 mg | Oral | NuCare Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 0.5 mg | Oral | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | NuCare Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | NuCare Pharmaceuticals,Inc. × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 2 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 4 listings | ANDA | View NDC → |
| 1 mg | Oral | PharmPak, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Preferred Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Preferred Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 0.5 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| 1 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| 0.5 mg | Oral | RedPharm Drug, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Remedyrepack Inc. × 6 listings | ANDA | View NDC → |
| 2 mg | Oral | Remedyrepack Inc. × 3 listings | ANDA | View NDC → |
| 0.5 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | St. Mary's Medical Park Pharmacy | ANDA | View NDC → |
| 1 mg | Oral | St. Mary's Medical Park Pharmacy | ANDA | View NDC → |
| 0.5 mg | Oral | Sun Pharmaceutical Industries Inc | ANDA | View NDC → |
| 1 mg | Oral | Sun Pharmaceutical Industries Inc | ANDA | View NDC → |
| 2 mg | Oral | Sun Pharmaceutical Industries Inc | ANDA | View NDC → |
| 0.5 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 0.5 mg | Oral | Unit Dose Solutions, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Unit Dose Solutions, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Unit Dose Solutions, Inc. | ANDA | View NDC → |
Showing 147 of 147 products — FDA National Drug Code Directory. See every product, package size and price: browse all 147 Lorazepam NDCs →
Lorazepam side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Lorazepam — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Lorazepam in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Lorazepam FDA approval history
How Lorazepam went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Lorazepam recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 3 Lorazepam recalls since July 2021, covering 6 product listings. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25 Lots: Lot # K24118, exp. date 10/31/2026 FDA record D-0551-2025 →
- Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDC 0641-6044-25), Rx only, Manufactured by West-Ward, Eatontown, NJ 07724. Lots: Lots: 070086, 070128, Exp. 07/2023 FDA record D-0574-2023 →
- Lorazepam Injection, USP, 4mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# NDC# 0641-6045-25, Vial NDC# 0641-6045-01 Lots: Lot # 070096, exp. date 07/2023 FDA record D-1310-2022 →
- Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01 Lots: Lot # 070088, exp. date 07/2023 FDA record D-1309-2022 →
- Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6001-25, Vial NDC# 0641-6001-01 Lots: Lot # 060064Z, Exp. 06/2023 FDA record D-1308-2022 →
- Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6044-25, Vial NDC# 0641-6044-01 Lots: Lot # 060064, Exp. 06/2023, 070084, Exp. 07/2023, 070126, Exp. 07/2023, 080091, Exp. 08/2023, 080060, Exp. 08/2023 FDA record D-1307-2022 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 6470 6 dose forms · 14 strengths
-
Dose form (SCDF) Cartridge RxCUI 1664995No current FDA listingClinical drug / strength (SCD) 1 ML lorazepam 2 MG/MLRxCUI 763028 -
Dose form (SCDF) Extended Release Oral Capsule RxCUI 446182In current FDA listingsClinical drug / strength (SCD) 24 HR lorazepam 1 MGRxCUI 256956424 HR lorazepam 1.5 MGRxCUI 259460024 HR lorazepam 2 MGRxCUI 256957324 HR lorazepam 3 MGRxCUI 2569577 -
Dose form (SCDF) Injectable Solution RxCUI 372645In current FDA listings -
Dose form (SCDF) Injection RxCUI 1665187In current FDA listingsClinical drug / strength (SCD) 1 ML lorazepam 2 MG/MLRxCUI 16651881 ML lorazepam 4 MG/MLRxCUI 1665326 -
Dose form (SCDF) Oral Solution RxCUI 372644In current FDA listingsClinical drug / strength (SCD) 2 MG/MLRxCUI 311376 -
Dose form (SCDF) Oral Tablet RxCUI 372647In current FDA listings
Look up RxCUI 6470 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Lorazepam supply and shortage status
Whether Lorazepam is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Lorazepam costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 1 mg | $0.037 per tablet | NDC details & price history |
| Tablet · Oral | 0.5 mg | $0.034 per tablet | NDC details & price history |
| Tablet · Oral | 2 mg | $0.073 per tablet | NDC details & price history |
| Capsule, Extended Release · Oral | 2 mg | $14.19 per capsule | NDC details & price history |
| Capsule, Extended Release · Oral | 3 mg | $14.23 per capsule | NDC details & price history |
| Capsule, Extended Release · Oral | 1.5 mg | $14.25 per capsule | NDC details & price history |
| Capsule, Extended Release · Oral | 1 mg | $14.21 per capsule | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Lorazepam brand names
Lorazepam is sold under 4 brand names in the FDA directory — Ativan, Lorazepam Intensol, Loreev Xr, Loreev. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Lorazepam: manufacturers and labelers
36 companies list Lorazepam products with the FDA. By number of product records, the largest are Aphena Pharma Solutions - Tennessee, LLC, Hikma Pharmaceuticals USA Inc., Remedyrepack Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 12 more on the FDA NDC directory.
Lorazepam drug class (RxNorm)
Lorazepam belongs to the Benzodiazepine class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Lorazepam page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Almatica Pharma LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →